Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115
Clinical trial NCT02185014 · COMPLETED
Trial details
- NCT number
- NCT02185014
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-12
- Primary completion
- 2017-11-03
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.